Physician Wealth Advisors’s Nutanix NTNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14K Sell
274
-19
-6% -$859 ﹤0.01% 783
2026
Q1
$11.1K Buy
293
+29
+11% +$1.22K ﹤0.01% 770
2025
Q4
$13.6K Buy
264
+11
+4% +$672 ﹤0.01% 683
2025
Q3
$18.8K Hold
253
﹤0.01% 589
2025
Q2
$19.3K Hold
253
﹤0.01% 524
2025
Q1
$17.7K Hold
253
﹤0.01% 510
2024
Q4
$15.5K Buy
+253
New +$16.5K ﹤0.01% 551

Other funds holding NTNX

Physician Wealth Advisors's NTNX Position: Q2 2026 in Review

Physician Wealth Advisors reduced its Nutanix (NTNX) stake by 6.5% in Q2 2026, selling an estimated $859 and leaving 274 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #783.

Physician Wealth Advisors first reported a position in NTNX in Q4 2024 and has held it in 7 quarters since. The position peaked at $19.3K in Q2 2025. 564 funds tracked by Wall St. Rank hold NTNX as of Q2 2026.

  • Physician Wealth Advisors held 274 shares of Nutanix worth $14K as of Q2 2026.
  • Physician Wealth Advisors sold 19 Nutanix shares in Q2 2026, an estimated $859.
  • Nutanix made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #783 holding.
  • Physician Wealth Advisors first reported a position in Nutanix in Q4 2024 and has held it in 7 quarters since.
  • Physician Wealth Advisors's Nutanix position peaked at $19.3K in Q2 2025.
  • 564 funds tracked by Wall St. Rank held Nutanix as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.